Niklas K Björkström Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2020

Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Niklas K Björkström Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 02/2007
13	Infections 01/2024 - 05/2010
9	COVID-19 02/2024 - 01/2020
6	Chronic Hepatitis C 01/2022 - 11/2009
5	Inflammation (Inflammations) 02/2023 - 10/2019
5	Cholangiocarcinoma 01/2023 - 06/2013
4	Chronic Hepatitis B 12/2023 - 01/2018
4	Fibrosis (Cirrhosis) 01/2023 - 01/2020
4	Hepatitis C 01/2022 - 05/2012
4	Virus Diseases (Viral Diseases) 01/2022 - 11/2009
3	Obesity 01/2023 - 01/2022
3	Sclerosing Cholangitis 01/2022 - 06/2013
3	Hepatitis 01/2022 - 05/2014
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 09/2009
2	Insulin Resistance 01/2022 - 01/2020
2	Liver Diseases (Liver Disease) 01/2022 - 05/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024
1	Breakthrough Infections 12/2023
1	Pneumonia (Pneumonitis) 02/2023
1	Convalescence 02/2023
1	Sepsis (Septicemia) 02/2023
1	Cytokine Release Syndrome 02/2023
1	Human Influenza (Influenza) 02/2023
1	Septic Shock (Toxic Shock Syndrome) 02/2023
1	Klatskin Tumor 01/2023
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2023
1	Cholangitis 01/2021
1	End Stage Liver Disease 12/2020
1	Ascites 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Persistent Infection 01/2020
1	Bile Duct Neoplasms (Bile Duct Cancer) 10/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Blister (Bulla) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Hepatitis B 01/2018
1	Bile Duct Diseases (Bile Duct Disease) 01/2018
1	Parasitemia 01/2016
1	Malaria 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2013
1	Leukemia 10/2012

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2023 - 05/2012
7	LigandsIBA 01/2023 - 02/2007
7	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2012
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2011
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2023 - 01/2018
4	AntigensIBA 12/2023 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
3	Hepatitis B e AntigensIBA 12/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2010
3	InterferonsIBA 01/2016 - 05/2012
2	ProteomeIBA 02/2023 - 01/2022
2	Blood Proteins (Serum Proteins)IBA 02/2023 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2019
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023 - 01/2022
2	AntibodiesIBA 01/2021 - 06/2013
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2020 - 09/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019 - 02/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2018
2	KIR ReceptorsIBA 10/2012 - 02/2012
2	CD226 antigenIBA 05/2012 - 02/2007
2	Natural Killer Cell ReceptorsIBA 05/2012 - 02/2010
2	Ribavirin (Virazole)FDA LinkGeneric 05/2010 - 11/2009
1	Interferon Type IIBA 02/2024
1	AutoantibodiesIBA 02/2024
1	CeramidesIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	sofosbuvir drug combination ledipasvirIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	XenobioticsIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020
1	ChemokinesIBA 10/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2019
1	AlbuminsIBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 07/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 02/2016
1	Sorafenib (BAY 43-9006)FDA Link 02/2016
1	Platelet-Derived Growth FactorIBA 02/2016
1	Sunitinib (Sutent)FDA Link 02/2016
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2016
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2016
1	VaccinesIBA 01/2016
1	Immunoglobulin A (IgA)IBA 06/2013
1	Therapeutic UsesIBA 05/2012
1	Interleukin-2 (IL2)IBA 05/2012

Therapy/Procedure

8	Therapeutics 12/2023 - 05/2010
6	Immunotherapy 01/2022 - 02/2007
2	Liver Transplantation 01/2019 - 01/2018
2	Stem Cell Transplantation 10/2012 - 11/2008
1	Withholding Treatment 12/2023